2 results about "Abutilon" patented technology

The application discloses a Talaromyces purpureogenus and application thereof in weeding, and belongs to the technical field of bioengineering and weeding, wherein the Talaromyces purpureogenus is named as CY-1, is preserved in the China General Microbiological Culture Collection Center, and has a preservation date of May 23, 2022 and a preservation number of CGMCC No.40203. Metabolic products of the Talaromyces purpureogenus CY-1 in the application can effectively inhibit broadleaf weeds such as amaranthus retroflexus, alternanthera philoxeroides, xanthium, chenopodium album, solanum nigrum, bidens pilosa, comphre, sonchus oleraceus, pteris cretica, medicago sativa, ipomoea hederifolia, rumex patientia, galium aparine, abutilon theophrasti, portulaca oleracea, leonurus japonicus, veronica anagallis, and aster spathulifolius, and the Talaromyces purpureogenus CY-1 is green and efficient in weeding, and has a wide application prospect in weeding.

The application belongs to the technical field of biological medicine, and relates to a herba abutilon polysaccharide, a preparation method thereof and application thereof. The herba abutilon is subjected to enzymolysis by using a composite enzyme liquid containing papain, pectinase and cellulase, and is subjected to ultrasonic extraction after the enzymolysis; the extraction liquid after extraction is purified and dried to obtain the herba abutilon polysaccharide; wherein the mass ratio of the papain, the pectinase and the cellulase is (0.5-1.5):(0.5-1.5):(0.5-1.5), and the enzyme dosage is 1-3% of the mass of the herba abutilon. The herba abutilon polysaccharide provided by the application has higher anti-inflammatory, antioxidant, intestinal barrier repair and other effects, and can play the efficacy of treating ulcerative colitis through a multi-level cascade action mechanism of'regulating intestinal flora-promoting SCFAs generation-enhancing intestinal barrier-inhibiting inflammatory reaction'.